首页> 外文期刊>Journal of psychopharmacology >The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression
【24h】

The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression

机译:FKBP5多态性rs1360780影响基于算法的抗抑郁药治疗的效果,并与重度抑郁症患者的缓解相关

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The FKBP5-gene influences the HPA-system by modulating the sensitivity of the glucocorticoid receptor (GR). The polymorphism rs1360780 has been associated with response in studies with heterogeneous antidepressant treatment. In contrast, several antidepressant studies with standardized antidepressant treatment could not detect this effect. We therefore compared patients with standardized vs naturalistic antidepressant treatment to (a) investigate a possible interaction between FKBP5-genotype and treatment mode and (b) replicate the effect of the FKBP5-genotype on antidepressant treatment outcome.
机译:目的:FKBP5基因通过调节糖皮质激素受体(GR)的敏感性影响HPA系统。 rs1360780多态性已与异质抗抑郁药治疗的反应相关联。相反,一些采用标准抗抑郁药治疗的抗抑郁药研究无法检测到这种作用。因此,我们将标准抗抑郁药与自然抗抑郁药的患者进行比较,以(a)研究FKBP5基因型与治疗模式之间可能的相互作用,以及(b)复制FKBP5基因型对抗抑郁药治疗效果的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号